Edinburgh Research Explorer

HO-1 drives autophagy as a mechanism of resistance against HER2-targeted therapies

Research output: Contribution to journalArticle

Standard

HO-1 drives autophagy as a mechanism of resistance against HER2-targeted therapies. / Tracey, Natasha; Creedon, Helen; Kemp, Alain J; Culley, Jayne; Muir, Morwenna; Klinowska, Teresa; Brunton, Valerie.

In: Breast cancer research and treatment, 08.11.2019.

Research output: Contribution to journalArticle

Harvard

Tracey, N, Creedon, H, Kemp, AJ, Culley, J, Muir, M, Klinowska, T & Brunton, V 2019, 'HO-1 drives autophagy as a mechanism of resistance against HER2-targeted therapies', Breast cancer research and treatment. https://doi.org/10.1007/s10549-019-05489-1

APA

Tracey, N., Creedon, H., Kemp, A. J., Culley, J., Muir, M., Klinowska, T., & Brunton, V. (2019). HO-1 drives autophagy as a mechanism of resistance against HER2-targeted therapies. Breast cancer research and treatment. https://doi.org/10.1007/s10549-019-05489-1

Vancouver

Tracey N, Creedon H, Kemp AJ, Culley J, Muir M, Klinowska T et al. HO-1 drives autophagy as a mechanism of resistance against HER2-targeted therapies. Breast cancer research and treatment. 2019 Nov 8. https://doi.org/10.1007/s10549-019-05489-1

Author

Tracey, Natasha ; Creedon, Helen ; Kemp, Alain J ; Culley, Jayne ; Muir, Morwenna ; Klinowska, Teresa ; Brunton, Valerie. / HO-1 drives autophagy as a mechanism of resistance against HER2-targeted therapies. In: Breast cancer research and treatment. 2019.